Shalby Limited , a leading healthcare services provider, has announced its financial results for the second quarter of fiscal year 2026, along with key corporate actions including the appointment of a new Chief Financial Officer and a restructuring of its subsidiary operations.

Financial Performance

Shalby delivered robust quarterly results for Q2 FY26:

• Consolidated revenue from operations: ₹2.85 billion, up from ₹2.67 billion year-on-year, representing a 6.7% increase
• Consolidated net profit: ₹83.80 million, surging from ₹34.00 million in the same period last year, marking a 146% increase
• EBITDA: ₹416.00 million, with margin expansion to 14.58% from 12.2%, indicating improved operational efficiency and profitability

Segment-wise Performance

Appointment of New CFO

Shalby Limited has appointed Mr. Amit Kumar as its new Chief Financial Officer and Key Managerial Personnel, effective November 13, 2025. Mr. Kumar's profile includes:

• Chartered Accountant with a Master's degree in Financial Management
• Over 18 years of experience across EdTech, Mobility, and Telecom sectors
• Expertise in controllership, commercial finance, FP&A, taxation, and M&A integration

Subsidiary Restructuring

The company has announced a restructuring of its subsidiary operations:

1. Shalby Advanced Technologies, Inc. USA (SAT Inc.) has approved the sale of its entire shareholding in Shalby Advanced Technologies India Private Limited (SAT India) to Shalby Medtech Limited (SMTL), a wholly-owned subsidiary of Shalby Limited.
2. SAT Inc. has granted license and manufacturing rights to SAT India for licensed products in India and international markets.
3. SAT India will provide Product Design and Engineering services to SAT Inc.
4. SAT India has become a wholly-owned subsidiary of SMTL and a step-down subsidiary of Shalby Ltd.

This restructuring aims to align strategies on marketing and product development across the group's subsidiaries.

Outlook

The strategic moves, including the appointment of an experienced CFO and the restructuring of subsidiary operations, indicate Shalby Limited's focus on strengthening its financial management and optimizing its corporate structure. The company appears to be positioning itself for improved operational efficiency in both its healthcare services and manufacturing segments. The significant increase in net profit and margin expansion demonstrate the company's ability to enhance its financial performance and operational efficiency.

Shalby Limited , a prominent healthcare company, has issued a corporate guarantee in favor of HDFC Bank Limited. The guarantee, amounting to ₹716.00 crore, is intended to support credit facilities granted to its subsidiary, PK Healthcare Private Limited.

Key Details of the Corporate Guarantee

Implications and Disclosures

Shalby Limited has provided important disclosures regarding this financial move:

1. Interest Declaration: The company has stated that promoters and promoter group companies do not have any interest in this transaction.

2. Subsidiary Involvement: PK Healthcare Private Limited, as the recipient of the credit facilities, is noted to have an interest in the transaction.

3. Financial Impact: Shalby Limited expects no financial or operational impact from providing this guarantee.

This corporate action demonstrates Shalby Limited's support for its subsidiary's financial needs while maintaining transparency about the transaction's nature and potential impacts. The size of the guarantee, at ₹716.00 crore, underscores the significance of this financial commitment and the scale of credit facilities being extended to PK Healthcare Private Limited.

Investors and stakeholders may view this move as an indication of Shalby Limited's confidence in its subsidiary's operations and future prospects. However, it's important to note that while the company anticipates no direct financial or operational impact, corporate guarantees do represent contingent liabilities that could potentially affect the guarantor's financial position in the future.